Clinical Trials · NCT00189514

A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Name: A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Pramlintide

Phase: Phase 2
Recruitment status: Completed
Sponsor: AstraZeneca
Enrollment: 210
Start date: Sep 2005
Locations: 21 sites, United States
Primary endpoint: Examine the long-term effect of subcutaneously (SC) injected pramlintide on body weight in obese subjects.

View Pramlintide compound reference